DUTASTERIDE 0.1%
DUTASTERIDE 0.1%
Single-compound, solvent-based topical research formulation developed for localized, non-clinical androgen receptor interaction studies.
Prefer email communication?
Request this formulation via our consultation form.
Request-only supply. No instant checkout. All formulation requests are reviewed before fulfilment.
Technical Data
Chemical Identification
GG745
GI198745
Physicochemical Characteristics
Documentation & Analytical Data
Research Documentation
Formulation Specification
Concentration system: 0.1% w/v
Equivalent concentration: 1 mg/mL
Total active content: 50 mg per 50 mL
Vehicle system: Ethanol 96% (Ph. Eur.) / Propylene Glycol (Ph. Eur.) / Diethylene Glycol Monoethyl Ether — Transcutol® P (Ph. Eur.) / Dimethyl Isosorbide
Solvent ratio: 45 / 12.5 / 30 / 12.5
Formulation architecture: Multi-solvent topical carrier system designed to support compound solubility, formulation consistency, and controlled surface application modeling.
Water content: No added water
Formulation complexity: Single-compound system
Research Context
Dutasteride is a dual 5α-reductase inhibitor investigated within non-clinical research models involving localized androgen metabolism pathway modulation and tissue-level enzymatic interaction behavior.
In topical research contexts, Dutasteride formulations are commonly evaluated as surface-applied compounds where localized delivery behavior, carrier-system compatibility, and controlled androgen metabolism pathway interaction are relevant experimental parameters.
Experimental focus is generally directed toward localized dual 5α-reductase modulation models, formulation dispersion behavior, and controlled surface-level interaction architecture within non-clinical laboratory environments.
This GeneTherica formulation is positioned as a research-grade topical solution for controlled, non-clinical laboratory use. It is not supplied for therapeutic, diagnostic, cosmetic, or human application.
Storage & Handling
Storage range: 2–8°C preferred; 15–25°C acceptable for short-term controlled handling.
Storage conditions: Store tightly closed in a cool, dry, dark environment.
Light sensitivity: Protect from direct sunlight and UV exposure.
Temperature stability: Avoid freezing and excessive heat exposure.
Air exposure: Minimize prolonged exposure to air.
Closure requirement: Keep container tightly sealed when not in use.
Stability context: Storage conditions are intended to support solvent balance, formulation consistency, and compound integrity during controlled non-clinical handling.
Research Use Notice
Supplied exclusively for laboratory research and analytical applications.
Not intended for therapeutic, cosmetic, veterinary, food, household, diagnostic, or human application.
Handling should occur within qualified non-clinical research environments only.
Overview
Dutasteride is a dual 5α-reductase inhibitor investigated within controlled research environments involving localized androgen metabolism and tissue-level enzyme interaction models.
Within topical research frameworks, Dutasteride formulations are primarily examined for their role in localized testosterone-to-dihydrotestosterone conversion pathways within surface-confined application environments.
Experimental focus is generally directed toward localized enzyme interaction, androgen-related signaling behavior, carrier-system compatibility, and controlled tissue-level delivery architecture.
Research applications emphasize surface-confined topical delivery systems designed to support localized formulation behavior while limiting broader systemic exposure variables within non-clinical study models.
This formulation is presented as a research-grade topical solution intended exclusively for scientific, analytical, and laboratory-based investigation under appropriately controlled handling conditions.
